| Q59348969 | A correlation between capsid protein VP2 and the plaque morphology of African horse sickness virus in cell culture |
| Q39225705 | A reverse genetics system of African horse sickness virus reveals existence of primary replication. |
| Q36193053 | An Inhibitory Motif on the 5'UTR of Several Rotavirus Genome Segments Affects Protein Expression and Reverse Genetics Strategies |
| Q37174442 | Assembly of Replication-Incompetent African Horse Sickness Virus Particles: Rational Design of Vaccines for All Serotypes |
| Q34768968 | Assortment and packaging of the segmented rotavirus genome. |
| Q36303999 | B-cell epitopes of African horse sickness virus serotype 4 recognised by immune horse sera. |
| Q37616773 | Bluetongue vaccines. |
| Q34081742 | Bluetongue virus VP1 polymerase activity in vitro: template dependency, dinucleotide priming and cap dependency |
| Q38246708 | Bluetongue virus capsid assembly and maturation. |
| Q27319898 | Bluetongue viruses based on modified-live vaccine serotype 6 with exchanged outer shell proteins confer full protection in sheep against virulent BTV8 |
| Q36253330 | Comparative analysis of Reoviridae reverse genetics methods |
| Q35665794 | Complete genomic sequence of bluetongue virus serotype 1 from China |
| Q35756880 | Development of reverse genetics for Ibaraki virus to produce viable VP6-tagged IBAV. |
| Q28551423 | Disruption of Specific RNA-RNA Interactions in a Double-Stranded RNA Virus Inhibits Genome Packaging and Virus Infectivity |
| Q34276415 | Dual selection mechanisms drive efficient single-gene reverse genetics for rotavirus |
| Q38627566 | Elucidating virus entry using a tetracysteine-tagged virus. |
| Q42274725 | Experimental co-infections of calves with bluetongue virus serotypes 1 and 8. |
| Q31137956 | Experimental pathways towards developing a rotavirus reverse genetics system: synthetic full length rotavirus ssRNAs are neither infectious nor translated in permissive cells |
| Q37372492 | Further characterisation of rotavirus cores: Ss(+)RNAs can be packaged in vitro but packaging lacks sequence specificity |
| Q34204054 | Generation of replication-defective virus-based vaccines that confer full protection in sheep against virulent bluetongue virus challenge |
| Q41817570 | Genetic modification of Bluetongue virus by uptake of "synthetic" genome segments. |
| Q59353891 | Genome packaging in multi-segmented dsRNA viruses: distinct mechanisms with similar outcomes |
| Q34126290 | Identification and characterization of a novel non-structural protein of bluetongue virus |
| Q45324799 | Interaction between a unique minor protein and a major capsid protein of Bluetongue virus controls virus infectivity |
| Q38992837 | Interaction between hantavirus nucleocapsid protein (N) and RNA-dependent RNA polymerase (RdRp) mutants reveals the requirement of an N-RdRp interaction for viral RNA synthesis |
| Q39431535 | Isolation of bluetongue virus serotype 1 from Culicoides vector captured in livestock farms and sequence analysis of the viral genome segment-2. |
| Q41895260 | Mapping overlapping functional elements embedded within the protein-coding regions of RNA viruses |
| Q36559484 | Minimum requirements for bluetongue virus primary replication in vivo. |
| Q42020965 | Molecular characterization of genome segment 2 encoding RNA dependent RNA polymerase of Antheraea mylitta cytoplasmic polyhedrosis virus |
| Q28482273 | Novel virostatic agents against bluetongue virus |
| Q91728852 | PCR-based reverse genetics strategy for bluetongue virus recovery |
| Q41835715 | Physicochemical analysis of rotavirus segment 11 supports a 'modified panhandle' structure and not the predicted alternative tRNA-like structure (TRLS). |
| Q39193743 | Protective efficacy of multivalent replication-abortive vaccine strains in horses against African horse sickness virus challenge |
| Q35128134 | RNA elements in open reading frames of the bluetongue virus genome are essential for virus replication |
| Q37123514 | Rapid generation of replication-deficient monovalent and multivalent vaccines for bluetongue virus: protection against virulent virus challenge in cattle and sheep |
| Q33990720 | Rearranged genomic RNA segments offer a new approach to the reverse genetics of rotaviruses. |
| Q99202263 | Recombinant bluetongue virus with hemagglutinin epitopes in VP2 has potential as a labeled vaccine |
| Q37512822 | Replication-Deficient Particles: New Insights into the Next Generation of Bluetongue Virus Vaccines. |
| Q40628405 | Requirements and comparative analysis of reverse genetics for bluetongue virus (BTV) and African horse sickness virus (AHSV). |
| Q27309749 | Rescue of recent virulent and avirulent field strains of bluetongue virus by reverse genetics |
| Q97564052 | Reverse genetics approaches: a novel strategy for African horse sickness virus vaccine design |
| Q33911145 | Rotavirus rearranged genomic RNA segments are preferentially packaged into viruses despite not conferring selective growth advantage to viruses |
| Q26996393 | Rotaviruses |
| Q34196457 | Structural constraints in the packaging of bluetongue virus genomic segments |
| Q39225680 | Structure based modification of Bluetongue virus helicase protein VP6 to produce a viable VP6-truncated BTV. |
| Q35178437 | Structure-based identification of functional residues in the nucleoside-2'-O-methylase domain of Bluetongue virus VP4 capping enzyme. |
| Q64266203 | The Interaction of Bluetongue Virus VP6 and Genomic RNA Is Essential for Genome Packaging |
| Q38174017 | The molecular biology of Bluetongue virus replication |
| Q30603531 | Trafficking of bluetongue virus visualized by recovery of tetracysteine-tagged virion particles. |
| Q64916780 | Transcriptome analysis of responses to bluetongue virus infection in Aedes albopictus cells. |
| Q36086306 | Turnover Rate of NS3 Proteins Modulates Bluetongue Virus Replication Kinetics in a Host-Specific Manner |